Latest Beauty News: Find a vaccine which offer treatment for acne

Follow us on

One day, you don't follow your night-time beauty regime and it results in breakout? Do you often suffer from acne?

Also Read -5 step beauty regime to follow at night | Flawless beauty hacks

Well, here's a good news! A potential vaccine that targets the bacterial toxins may soon be on the anvil, say researchers.

Instead of invading pathogens, the new vaccine would be the first to target bacteria already in human skin.

The researchers demonstrated that antibodies to a toxin secreted from bacteria in acne vulgaris can reduce inflammation in human acne lesions.

"Once validated by a large-scale clinical trial, the potential impact of our findings is huge for the hundreds of millions of individuals suffering from acne vulgaris," explained lead investigator Chun-Ming Huang, from the University of California-San Diego, US.

Also Read -Eating healthy can help you keep acne at bay

An acne vaccination could circumvent potential adverse effects of topical or systemic retinoids and antibiotics, the current treatment options.

They found that Christie-Atkins-Munch-Peterson (CAMP) factor -a toxin secreted from the Propionibacterium acnes (P. acnes) bacteria, can induce inflammatory responses.

In the study, published in the Journal of Investigative Dermatology, the team explored in mice and ex vivo in human skin cells whether they could inhibit inflammation by employing antibodies to neutralise this virulence factor.

Their findings show that the application of monoclonal antibodies to CAMP 2 factor did indeed decrease the inflammatory response.

Also Read -Latest Beauty News | Aromatherapy brings holistic approach to beauty

"While addressing an unmet medical need and providing an appealing approach, acne immunotherapies that target P. acnes-derived factors have to be cautiously designed to avoid unwanted

disturbance of the microbiome that guarantees skin homeostasis," said Emmanuel Contassot, from the University of Zurich in Switzerland.

Future studies will address these factors and focus on engineering a non-toxic chemical or targeted vaccine formulation for its human application, the researchers said.

(With IANS Inputs)

For latest lifestyle updates, check out our Facebook page!